Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.

about

Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.

Item

http://www.wikidata.org/entity/Q50062242

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@en

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@nl

type

Item

label

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@en

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@nl

prefLabel

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@en

Comparative Effectiveness of T ...... he First Year after Diagnosis.

@nl

P1476

Comparative Effectiveness of T ...... The First Year after Diagnosis

@en

P2093

Chris Feudtner

http://www.w3.org/2001/XMLSchema#string

Esi Morgan-DeWitt

http://www.w3.org/2001/XMLSchema#string

Ilaria Pagnini

http://www.w3.org/2001/XMLSchema#string

Pamela F Weiss

http://www.w3.org/2001/XMLSchema#string

Rui Xiao

http://www.w3.org/2001/XMLSchema#string

Timothy Beukelman

http://www.w3.org/2001/XMLSchema#string

Tracey B Wright

http://www.w3.org/2001/XMLSchema#string

P2860

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

Marginal structural models and causal inference in epidemiology

Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

Development and retrospective validation of the juvenile spondyloarthritis disease activity index

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Assessment of Sacroiliitis at Diagnosis of Juvenile Spondyloarthritis by Radiography, Magnetic Resonance Imaging, and Clinical Examination.

Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis.

P304

107-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.170251

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timothy G Brandon

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28916542

http://www.w3.org/2001/XMLSchema#string

P932

5750113

http://www.w3.org/2001/XMLSchema#string